These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18674899)

  • 21. Scaffold oriented synthesis. Part 1: Design, preparation, and biological evaluation of thienopyrazoles as kinase inhibitors.
    Akritopoulou-Zanze I; Darczak D; Sarris K; Phelan KM; Huth JR; Song D; Johnson EF; Jia Y; Djuric SW
    Bioorg Med Chem Lett; 2006 Jan; 16(1):96-9. PubMed ID: 16216502
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New 4-[(1-benzyl-1H-indol-3-yl)carbonyl]-3-hydroxyfuran-2(5H)-ones, beta-diketo acid analogs as HIV-1 integrase inhibitors.
    Ferro S; Barreca ML; De Luca L; Rao A; Monforte AM; Debyser Z; Witvrouw M; Chimirri A
    Arch Pharm (Weinheim); 2007 Jun; 340(6):292-8. PubMed ID: 17562561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and in vitro anti-hepatitis B virus activities of 4-aryl-6-chloro-quinolin-2-one and 5-aryl-7-chloro-1,4-benzodiazepine derivatives.
    Cheng P; Zhang Q; Ma YB; Jiang ZY; Zhang XM; Zhang FX; Chen JJ
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3787-9. PubMed ID: 18524583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Synthesis of baicalin derivatives and evaluation of their anti-human immunodeficiency virus (HIV-1) activity].
    Zhao J; Zhang Z; Chen H; Zhang X; Chen X
    Yao Xue Xue Bao; 1998; 33(1):22-7. PubMed ID: 11938930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Caffeoylglycolic and caffeoylamino acid derivatives, halfmers of L-chicoric acid, as new HIV-1 integrase inhibitors.
    Lee SU; Shin CG; Lee CK; Lee YS
    Eur J Med Chem; 2007 Oct; 42(10):1309-15. PubMed ID: 17434650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antiviral activity of 7-benzyl-4-hydroxy-1,5-naphthyridin-2(1H)-one HIV integrase inhibitors.
    Boros EE; Edwards CE; Foster SA; Fuji M; Fujiwara T; Garvey EP; Golden PL; Hazen RJ; Jeffrey JL; Johns BA; Kawasuji T; Kiyama R; Koble CS; Kurose N; Miller WH; Mote AL; Murai H; Sato A; Thompson JB; Woodward MC; Yoshinaga T
    J Med Chem; 2009 May; 52(9):2754-61. PubMed ID: 19374386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigations on the 4-quinolone-3-carboxylic acid motif. 1. Synthesis and structure-activity relationship of a class of human immunodeficiency virus type 1 integrase inhibitors.
    Pasquini S; Mugnaini C; Tintori C; Botta M; Trejos A; Arvela RK; Larhed M; Witvrouw M; Michiels M; Christ F; Debyser Z; Corelli F
    J Med Chem; 2008 Aug; 51(16):5125-9. PubMed ID: 18665580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design and synthesis of specific inhibitors of the 3'-processing step of HIV-1 integrase.
    Chi G; Seo BI; Nair V
    Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):481-4. PubMed ID: 16247975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: effect of alkyl chain length.
    Mori S; Miyake S; Kobe T; Nakaya T; Fuller SD; Kato N; Kaihatsu K
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4249-52. PubMed ID: 18547804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A refined pharmacophore model for HIV-1 integrase inhibitors: Optimization of potency in the 1H-benzylindole series.
    De Luca L; Barreca ML; Ferro S; Iraci N; Michiels M; Christ F; Debyser Z; Witvrouw M; Chimirri A
    Bioorg Med Chem Lett; 2008 May; 18(9):2891-5. PubMed ID: 18417342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimization of 5-aryloxyimidazole non-nucleoside reverse transcriptase inhibitors.
    Jones LH; Allan G; Corbau R; Hay D; Middleton DS; Mowbray CE; Newman SD; Perros M; Randall A; Vuong H; Webster R; Westby M; Williams D
    ChemMedChem; 2008 Nov; 3(11):1756-62. PubMed ID: 18855969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and evaluation of 5'-modified 2'-deoxyadenosine analogues as anti-hepatitis C virus agents.
    Ikejiri M; Ohshima T; Fukushima A; Shimotohno K; Maruyama T
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4638-41. PubMed ID: 18644724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of nucleoside-based antiviral drugs in ionic liquids.
    Kumar V; Malhotra SV
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5640-2. PubMed ID: 18796352
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4-Alkyliden-beta-lactams conjugated to polyphenols: synthesis and inhibitory activity.
    Cainelli G; Galletti P; Garbisa S; Giacomini D; Sartor L; Quintavalla A
    Bioorg Med Chem; 2005 Nov; 13(22):6120-32. PubMed ID: 16084102
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antiviral activity of 4,4'-(arylmethylene)bis(1H-pyrazol-5-ols) against peste des petits ruminant virus (PPRV).
    Sujatha K; Shanthi G; Selvam NP; Manoharan S; Perumal PT; Rajendran M
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4501-3. PubMed ID: 19482473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and synthesis of novel nitrogen-containing polyhydroxylated aromatics as HIV-1 integrase inhibitors from caffeic acid phenethyl ester.
    Wang P; Liu C; Sanches T; Zhong Y; Liu B; Xiong J; Neamati N; Zhao G
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4574-8. PubMed ID: 19625188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-HBV agents. Part 2: synthesis and in vitro anti-hepatitis B virus activities of alisol A derivatives.
    Zhang Q; Jiang ZY; Luo J; Liu JF; Ma YB; Guo RH; Zhang XM; Zhou J; Chen JJ
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2148-53. PubMed ID: 19289281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of novel dihydroquinoline-3-carboxylic acids as HIV-1 integrase inhibitors.
    Sechi M; Rizzi G; Bacchi A; Carcelli M; Rogolino D; Pala N; Sanchez TW; Taheri L; Dayam R; Neamati N
    Bioorg Med Chem; 2009 Apr; 17(7):2925-35. PubMed ID: 19026554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Azaindole hydroxamic acids are potent HIV-1 integrase inhibitors.
    Plewe MB; Butler SL; Dress KR; Hu Q; Johnson TW; Kuehler JE; Kuki A; Lam H; Liu W; Nowlin D; Peng Q; Rahavendran SV; Tanis SP; Tran KT; Wang H; Yang A; Zhang J
    J Med Chem; 2009 Nov; 52(22):7211-9. PubMed ID: 19873974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design and synthesis of indole, 2,3-dihydro-indole, and 3,4-dihydro-2H-quinoline-1-carbothioic acid amide derivatives as novel HCV inhibitors.
    Kang IJ; Wang LW; Hsu SJ; Lee CC; Lee YC; Wu YS; Hsu TA; Yueh A; Chao YS; Chern JH
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4134-8. PubMed ID: 19539472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.